Author

Anthony Curtis

School of Pharmacy, Keele University - Cited by 1,096

Biography

Anthony Curtis is affiliated to Institute of Science and Technology in Medicine. He is a recipient of many awards and grants for his valuable contributions and discoveries in major area of subject research. His international experience includes various programs, contributions and participation in different countries for diverse fields of study. His research interests reflect in his wide range of publications in various national and international journals.
Title
Cited by
Year
Application of nanoparticle technologies in the combat against anti-microbial resistance
M Kumar, A Curtis, C HoskinsPharmaceutics 10 (1), 11, 2018201
116
2018
The use of nanotechnology in cardiovascular disease
M Chandarana, A Curtis, C HoskinsApplied Nanoscience 8, 1607-1619, 2018201
75
2018
Comprehensive heterocyclic chemistry III
DL Comins, S O’Connor, RS Al-awar, AR Katritzky, CA Ramsden, ...Alan, RK, 41, 200874200
74
2008
Synthesis and characterization of TPGS–gemcitabine prodrug micelles for pancreatic cancer therapy
V Khare, WA Sakarchi, PN Gupta, ADM Curtis, C HoskinsRsc Advances 6 (65), 60126-60137, 2016201
61
2016
Preclinical evaluation of statins as a treatment for ovarian cancer
E Robinson, M Nandi, LL Wilkinson, DM Arrowsmith, ADM Curtis, ...Gynecologic oncology 129 (2), 417-424, 2013201
55
2013
The use of iron oxide nanoparticles for pancreatic cancer therapy
M Malekigorji, ADM Curtis, C HoskinsJournal of Nanomedicine Research 1 (1), 2014201
50
2014
Nanotechnologies in pancreatic cancer therapy
A Manzur, A Oluwasanmi, D Moss, A Curtis, C HoskinsPharmaceutics 9 (4), 39, 2017201
46
2017
1, 2, 4‐Triazoles
ADM CurtisChemInform 36 (11), no-no, 2005200
44
2005
Stimuli responsive polymeric systems for cancer therapy
A Alsuraifi, A Curtis, DA Lamprou, C HoskinsPharmaceutics 10 (3), 136, 2018201
42
2018
Diels Alder-mediated release of gemcitabine from hybrid nanoparticles for enhanced pancreatic cancer therapy
A Oluwasanmi, W Al-Shakarchi, A Manzur, MH Aldebasi, RS Elsini, ...Journal of Controlled Release 266, 355-4, 2017201
36
2017
Simple calix [n] arenes and calix [4] resorcinarenes as drug solubilizing agents
C Hoskins, ADM CurtisJournal of Nanomedicine Research 2 (3), 2015201
33
2015
Product Class 14: 1, 2, 4-Triazoles
ADM CurtisScience of Synthesis 13, 603-639, 2004200
28
2004
Thermally triggered theranostics for pancreatic cancer therapy
M Malekigorji, M Alfahad, PKT Lin, S Jones, A Curtis, C HoskinsNanoscale 9 (34), 135-145, 2017201
27
2017
Interaction of a water soluble fullerene derivative with reactive oxygen species and model enzymatic systems
S Foley, ADM Curtis, A Hirsch, M Brettreich, A Pelegrin, P Seta, ...Fullerenes, Nanotubes and Carbon Nanostructures 10 (1), 49-67, 2002200
26
2002
Combined effect of anticancer agents and cytochrome C decorated hybrid nanoparticles for liver cancer therapy
W Al-Shakarchi, A Alsuraifi, M Abed, M Abdullah, A Richardson, A Curtis, ...Pharmaceutics 10 (2), 48, 2018201
25
2018
The Synthesis of C2-Symmetric and Axially Chiral Compounds for Recognition and Catalysis
J Clews, ADM Curtis, H MalkinTetrahedron 56 (44), 8735-8746, 000
20
2000
Investigation into drug solubilisation potential of sulfonated calix [4] resorcinarenes
C Hoskins, A Papachristou, TMH Ho, J Hine, ADM CurtisJournal of Nanomedicine and Nanotechnology 7 (2), 2016201
19
2016
Heat dissipation of hybrid iron oxide-gold nanoparticles in an agar phantom
ADM Curtis, M Malekigorji, J Holman, MA Skidmore, C HoskinsJournal of Nanomedicine and Nanotechnology 6 (6), 2015201
17
2015
Potential of hybrid iron oxide–gold nanoparticles as thermal triggers for pancreatic cancer therapy
A Oluwasanmi, M Malekigorji, S Jones, A Curtis, C HoskinsRSC advances 6 (97), 95044-95054, 2016201
17
2016
Silver-nanoparticle-mediated therapies in the treatment of pancreatic cancer
R Foulkes, M Ali Asgari, A Curtis, C HoskinsACS Applied Nano Materials 2 (4), 58-72, 2019201
17
2019